PubMed:35451728
A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II).
|
projects
Unselected / annnotation | Selected / annnotation | |
|
|
|